Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
20.50B | 19.97B | 19.32B | 16.67B | 15.43B | Gross Profit |
3.76B | 3.64B | 3.43B | 3.08B | 2.98B | EBIT |
772.21M | 800.42M | 737.99M | 617.32M | 642.39M | EBITDA |
1.03B | 1.03B | 951.24M | 815.37M | 809.85M | Net Income Common Stockholders |
534.42M | 523.74M | 513.18M | 426.65M | 421.03M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
28.27M | 36.05M | 33.91M | 45.44M | 43.52M | Total Assets |
7.07B | 6.68B | 6.35B | 5.70B | 5.41B | Total Debt |
2.84B | 2.99B | 3.09B | 2.98B | 3.23B | Net Debt |
2.82B | 2.96B | 3.05B | 2.93B | 3.18B | Total Liabilities |
5.22B | 5.22B | 5.30B | 5.05B | 5.09B | Stockholders Equity |
1.85B | 1.46B | 1.05B | 648.11M | 319.33M |
Cash Flow | Free Cash Flow | |||
312.89M | 251.81M | 417.63M | 527.14M | 650.21M | Operating Cash Flow |
900.87M | 718.88M | 788.16M | 831.65M | 868.55M | Investing Cash Flow |
-589.57M | -454.76M | -747.06M | -304.51M | -192.44M | Financing Cash Flow |
-319.08M | -261.98M | -52.63M | -525.23M | -662.79M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $460.02B | 60.53 | 32.89% | 0.45% | 6.13% | 12.14% | |
75 Outperform | $15.72B | 29.37 | 32.33% | ― | 2.67% | 2.72% | |
73 Outperform | $782.49B | 41.91 | 22.80% | 0.88% | 4.22% | -0.17% | |
68 Neutral | $45.92B | 18.77 | 26.59% | 1.80% | -1.94% | 23.94% | |
64 Neutral | $8.88B | 14.67 | 4.78% | 173.89% | 3.39% | 2.18% | |
62 Neutral | $44.52B | 11.06 | 29.08% | 4.54% | -0.69% | 2.03% | |
61 Neutral | $19.04B | ― | 18.88% | ― | -9.88% | -205.57% |